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Background. T2 inflammation of chronic rhinosinusitis with nasal polyps (CRSwNP) may be influenced by epithelial cytokines
release (TSLP, IL-25, and IL-33). We investigated the release of TSLP, IL-25, and IL-33 by epithelial CRSwNP cells compared to
epithelial sinusmucosa cells of patientswith chronic rhinosinusitis without nasal polyps (CRSsNP).Methods. IL-25, IL-33, andTSLP
were measured by ELISA in the supernatant of cell cultures derived by CRSwNP (9 patients, 6 atopic) and CRSsNP (7 patients, 2
atopic) in baseline condition and following stimulation withDermatophagoides pteronyssinus (DP),Aspergillus fumigatus (AF), and
poly(I:C). Results. CRSwNP epithelial cells released increased levels of IL-25 (from 0.12 ± 0.06 pg/ml to 0.27 ± 0.1 pg/ml, 𝑝 < 0.01)
and TSLP (from 0.77 ± 0.5 pg/ml to 2.53 ± 1.17 pg/ml, 𝑝 < 0.001) following poly(I:C) stimulation, while CRSsNP epithelial cells
released increased levels of IL-25 and IL-33 following AF and DP stimulation, respectively (IL-25: from 0.18 ± 0.07 pg/ml to 0.51
± 0.1 pg/ml, 𝑝 < 0.001; IL-33: from 2.57 ± 1.3 pg/ml to 5.7 ± 3.1 pg/ml, 𝑝 < 0.001). Conclusions. CRSwNP epithelial cells release
TSLP and IL-25 when stimulated by poly(I:C) but not by DP or AF, suggesting that viral infection may contribute to maintain and
amplify the T2 immune response seen in CRSwNP.
1. Introduction
Chronic rhinosinusitis without nasal polyps (CRSsNP) and
chronic rhinosinusitis with nasal polyps (CRSwNP) have
been considered as separate disease entities based on inflam-
matory and remodeling profiles with a predominance of TH1
cells in patients with CRSsNP and TH2 cells and eosinophils
in patients with CRSwNP [1]. Recent studies have questioned
this dichotomization of CRS [2], by reporting a wider spec-
trum of immunologic profiles. CRSwNP is generally charac-
terized by type 2 inflammationwith pronounced eosinophilia
and the presence of high levels of IL-5 and IL-13 in Western
countries, while neutrophilic and proinflammatory cytokines
have been reported to be predominant in Chinese patients
with nasal polyps [3], specifically in those patients who
were IL-5/IL-17/IFN-gamma negative [4]. On the other hand,
CRSsNP is no longer considered to be sustained by type 1
inflammation only, as initially reported by Van Zele et al. [5].
Heterogeneous inflammation may be observed in CRSsNP,
with different predominant cytokines, such as not only IFN-
gamma and IL-17A but also IL-5, similar to CRSwNP [2].
Epithelial cells are no more considered a mere physical
barrier in the mucosal sites, but they play also a key role
in the initiation and regulation of innate and adaptive im-
mune responses. Thymic stromal lymphopoietin (TSLP) and
other epithelial derived cytokines (interleukin-25, IL-25 and
interleukin-33, IL-33), the so-called tissue cytokines, consti-
tute a complex network for the regulation of immunity and
inflammation. The expression of such cytokines by epithelial
cells may be induced by different exogenous/endogenous
stimuli, as well as pathogens, traumas, infections, allergens,
Toll-like receptor ligands (TLR ligands), proinflammatory,
and T2 cytokines [6, 7].
The response of nasal epithelial cells to diverse stim-
uli such as inhaled allergens and nonallergic triggers may
play a role in the pathogenesis of chronic inflammatory
diseases, such as chronic rhinosinusitis without nasal polyps
(CRSsNP) and chronic rhinosinusitis with nasal polyps
(CRSwNP). TSLP has been found highly expressed in sinus
mucosa of patients with CRSwNP [8–11] and epithelial
production of IL-25, IL-33, and TSLP has emerged as critical
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epithelial factors that can initiate and amplify airway inflam-
mation [12, 13].
Viral infection may stimulate epithelial cells to produce
type 2 cytokines driving a biased inflammation toward a
type 2 immune response. The role of virus infection in the
pathogenesis of nasal polyps is not clear, but it has been
shown that respiratory virus genomes are commonly found
in in secretions and tissue samples from patients with CRS
[14]. To test the hypothesis that viral infection would induce
IL-25, IL-33, and TSLP release in epithelia derived from
CRSwNP patients, but not CRSsNP patients, we measured
the production of TSLP, IL-25, and IL-33 by epithelial cells
derived from nasal polyps of CRSwNP, in vitro exposed to
poly(I:C), a synthetic analog of viral dsRNAi, compared to
epithelial cells derived from sinus mucosa of CRSsNP.
Sinus bioptic samples were also stimulated with common
allergens, like Aspergillus and house dust mites, known to
activate epithelial cells due to their protease activity [15, 16].
2. Materials and Methods
2.1. Patients. Sixteen consecutive Caucasian patients, 8 male,
mean age of 49.33 ± 15.86 years (range 22–80 years) recruited
for functional endoscopic sinus surgery (FESS), at the 1st ENT
Division of the University of Turin, Italy, were enrolled in
this study, approved by the local ethics committee, having
obtained the written informed consent by all of them. All
the patients were affected by CRSwNP (𝑛 = 9, 6 atopic)
or CRSsNP (𝑛 = 7, 2 atopic). Diagnosis of CRSwNP
and CRSsNP was based on symptoms and fiber optical
examination and by sinus CT scan, according to European
Position Paper on Rhinosinusitis 2012 criteria [1].
Skin prick tests for a panel of 14 inhalant standard aller-
gens (ALK Abello’, Hørsholm, Denmark) were performed in
all included patients. Atopy was defined as a wheal diameter
3mm or greater in the presence of expected results in
control solutions (histamine dihydrochloride 20mg/ml as
a positive and solvent as a negative control). Measurement
of specific IgE antibodies against common allergens (CAP-
Phadia, Uppsala, Sweden) was performed in patients in
whom skin prick tests could not be performed.
None of our subjects had current respiratory tract infec-
tion and none of them was treated with systemic or nasal
corticosteroids or other medications in the four weeks prior
to inclusion.
The study was approved by our Institutional Ethics
Committee and all patients signed an informed consent to use
their clinical data for scientific purpose.
2.2. Sinus Biopsies. Biopsy specimens were collected from
nasal polyps of CRSwNP and in vitro exposed to different
stimuli, compared to epithelial cells derived from ethmoid
tissue of CRSsNP. All specimens were immediately placed
in BEGMmedium (Bronchial Epithelial Cell Growth Media,
Clonetics-Lonza) with no serum but supplemented with
penicillin 100U/ml, streptomycin 100 𝜇g/ml, and glutamine.
2.3. Epithelial Cell Culture. Tissue specimens were obtained
during surgery, from nasal polyps and ethmoid tissue of
patients with CRSwNP and CRSsNP, respectively. The sam-
ples were immediately placed in BEGM medium (Bronchial
Epithelial Cell Growth Media, Clonetics-Lonza) with no
serum, supplemented with penicillin 100U/ml, streptomycin
100 𝜇g/ml, and glutamine. Afterwards the samples were
washed twice in NaCl solution and cut into small pieces
(∼1mm2). Diced specimens were then plated (density, 9
pieces/6-well tissue culture dish) in BEGM medium and
incubated in a humidified 5% CO
2
atmosphere at 37∘C,
until a monolayer of epithelial-like cells was observed to
be confluent, usually after 13 ± 2 days. Then the explanted
tissues were removed, and cells were trypsinized and replated
into 6-well tissue culture dish at a final volume of 1.5ml of
fresh BEGMmedium.Themediumwas changed every 3 days
for 2-3 weeks until 90% confluence was obtained, usually
after 17 ± 3 days, when the cells were stimulated overnight.
To assess purity of the culture, cells were trypsinized and
washed and one aliquot was analyzed for EpCAM (epithelial
cells marker) expression with flow cytometry technique and
another aliquot was examined in the Bu¨rker chamber for
counting the number of cells.
2.4. Epithelial Cell Stimulation and EpCAM Evaluation.
Before stimulation, media were removed and replaced with
fresh media. Cells were stimulated with 25𝜇g/ml poly(I:C),
1.6 𝜇g/ml of Dermatophagoides pteronyssinus, and 2.6 𝜇g/ml
of Aspergillus fumigatus separately, for 24 h at 37∘C in 5%
CO
2
. As negative control epithelial cells were incubated
with culture medium only. Stimulated cell cultures were
centrifuged at 4∘C, and the supernatants were collected and
stored at −20∘C until being analyzed. Subsequently, cells
were trypsinized and washed and an aliquot was analyzed
for EpCAM (epithelial cells marker) expression with flow
cytometry technique; another aliquot was examined in the
Bu¨rker chamber for counting the number of stimulated cells.
The median cells number/well was 49312 ± 14645, and the
cells were always more than 90% EpCAM positive (94 ± 4
percentage of EpCAM positive cells). Staining for EpCAM
was performed using EpCAM-PE antibody (BioLegend, San
Diego, CA) on a Beckman Coulter XL cytometer.
2.5. Cytokine Production. Cell culture supernatants were
analyzed for cytokine release by a Multiplex Bio-Plex Tech-
nology by Bioclarma srl (Turin, Italy). Samples were unfrozen
overnight, then centrifuged, and analyzed for TSLP, IL-
25, and IL-33. The assay was performed according to the
manufacturer’s instructions.
2.6. Statistics. Statistical analysis was performed by using
GraphPad Prism 4.0c, GraphPad Software, Inc., CA, USA.
Data are given as means ± SD. Differences between groups
were tested by ANOVA followed by a post hoc test and an
unpaired two-tailed Student’s 𝑡-test and considered to be
significant when 𝑝 < 0.05. Differences in cytokine levels
before and after stimulation were tested by paired 𝑡-test.
3. Results
Clinical and demographic characteristics of the patients
are reported in Table 1. Baseline production of epithelial
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Table 1: Demographic and clinical characteristics of patients.
Patient
number
Age
(years) Gender Atopy Asthma Sensibilization Clinical diagnosis Surgery
1 22 Male Yes No
Grass and olive tree
pollen; house dust
mite; cat and dog
epithelia
CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
2 53 Female No No / CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
3 36 Male No No / CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
4 62 Female Yes No House dust mite; catepithelia CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
5 38 Male Yes Yes Grass pollen CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
6 55 Female Yes No Cat epithelia; grasspollen; moulds CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
7 60 Male Yes No
Grass and weed
pollen; house dust
mite
CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
8 47 Female Yes Yes
Grass, olive, hazelnut,
and plane tree pollen;
house dust mite
CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
9 59 Female No No / CRSwNP
Polypectomy, middle
antrostomy,
ethmoidectomy
10 56 Male Yes Yes House dust mite; catepithelia CRSsNP
Middle antrostomy,
ethmoidectomy
11 40 Female Yes No House dust mite; catand dog epithelia CRSsNP
Middle antrostomy,
ethmoidectomy
12 42 Female No No / CRSsNP Middle antrostomy,ethmoidectomy
13 27 Male No No / CRSsNP Middle antrostomy,ethmoidectomy
14 46 Female No No / CRSsNP Middle antrostomy,ethmoidectomy
15 70 Male No No / CRSsNP Middle antrostomy,ethmoidectomy
16 80 Male No No / CRSsNP Middle antrostomy,ethmoidectomy
cytokines was not different between epithelial cells derived
by nasal polyps and epithelial cells derived by ostiomeatal
mucosa of patients with CRSsNP (TSLP: 0.76 ± 0.48 pg/ml
versus 0.61 ± 0.48 pg/ml; IL-25: 0.13 ± 0.07 pg/ml versus 0.18
± 0.07 pg/ml; IL-33: 2.25± 1.26 pg/ml versus 2.56± 1.27 pg/ml,
resp.). All the results are shown in Figure 1 (IL-25), 2 (TSLP),
and 3 (IL-33).
3.1. Poly(I:C) Stimulation. Following poly(I:C) stimulation,
epithelial cells derived by nasal polyps released significantly
higher amounts of IL-25 (from 0.12 ± 0.06 pg/ml to 0.27
± 0.1 pg/ml, 𝑝 < 0.01; Figure 1) and TSLP (from 0.77 ±
0.5 pg/ml to 2.53 ± 1.17 pg/ml, 𝑝 < 0.001; Figure 2), with no
change in IL-33 (from 2.25 ± 1.2 pg/ml to 2.57 ± 0.9 pg/ml,
Figure 3). No change in cytokines release was observed in
cultures of epithelial cells derived fromostiomeatalmucosa of
patients with CRSsNP (IL-25: from 0.18 ± 0.07 pg/ml to 0.26
± 0.1 pg/ml; TSLP: from 0.61 ± 0.5 pg/ml to 0.91 ± 0.4 pg/ml;
IL-33: from 2.56 ± 1.3 pg/ml to 2.3 ± 0.6 pg/ml).
3.2. Allergen Stimulation. Following A. fumigatus and D.
pteronyssinus stimulation, epithelial cells derived from osti-
omeatal mucosa of patients with CRSsNP released signifi-
cantly higher amounts of IL-25 and IL-33, respectively, with
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Figure 1:Mean and single values of IL-25 release inCRSsNP andCRSwNPpatients. Bas =Baseline; A.f. =A. fumigatus; D.p. =D. pteronyssinus.
∗𝑝 < 0.001.
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Figure 2: Mean and single values of TSLP release in CRSsNP and CRSwNP patients. Bas = Baseline; A.f. = A. fumigatus; D.p. = D.
pteronyssinus. ∗𝑝 < 0.001.
no change inTSLP (A. fumigatus stimulation, IL-25: from0.18
± 0.07 pg/ml to 0.51 ± 0.1 pg/ml, 𝑝 < 0.001; D. pteronyssinus
stimulation, IL-33: from 2.56 ± 1.3 pg/ml to 5.7 ± 3.1 pg/ml,
𝑝 < 0.001; A. fumigatus and D. pteronyssinus stimulation,
TSLP: from 0.61 ± 0.5 pg/ml to 0.4 ± 0.1 pg/ml and from 0.61
± 0.5 pg/ml to 0.4 ± 0.1 pg/ml, resp.; see Figures 1, 2, and 3).
Following A. fumigatus and D. pteronyssinus stimulation,
no change in cytokines release was observed in epithelial
cells derived by nasal polyps of patients with CRSwNP
(A. fumigatus stimulation: IL-25 from 0.12 ± 0.06 pg/ml to
0.24 ± 0.09 pg/ml; IL-33 from 2.25 ± 1.2 pg/ml to 1.34 ±
0.7 pg/ml; TSLP from 0.77 ± 0.5 pg/ml to 0.43 ± 0.1 pg/ml; D.
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Figure 3:Mean and single values of IL-33 release inCRSsNPandCRSwNPpatients. Bas =Baseline; A.f. =A. fumigatus; D.p. =D. pteronyssinus.
∗𝑝 < 0.001.
pteronyssinus stimulation: IL-25 from0.12± 0.06 pg/ml to 0.15
± 0.06 pg/ml; IL-33 from 2.25 ± 1.2 pg/ml to 4.31 ± 3.4 pg/ml;
TSLP from 0.77 ± 0.5 pg/ml to 0.56 ± 0.2 pg/ml; see Figures
1, 2, and 3).
4. Discussion
Wereport that epithelial cells derived fromnasal polyps of pa-
tientswithCRSwNP releaseTSLP and IL-25when specifically
stimulated by poly(I:C), while they could not be activated
by the stimulation with Dermatophagoides pteronyssinus or
Aspergillus fumigatus extracts.
Poly(I:C) is a synthetic analog of viral dsRNA [17], which
have been shown to closely mimic inflammatory responses
associated with viral infection of airway epithelial cells [18].
Experimental data showed that TSLP may be induced by
rhinovirus infection or by exposure to double stranded (ds)
RNA (viral surrogate) in the lungs of allergic mice [19] and in
human bronchial epithelial cells (HBEC) [20]. More recently
Perez et al. reported increased levels of TSLP in nasal washes
obtained from newborns, infants, and toddlers with PCR-
confirmed acute rhinovirus infection, compared to controls
with no infection [21].
TSLP and TSLP receptor have been found highly ex-
pressed in sinusmucosa of patients with CRSwNP [8–11], and
a recent work by Golebski et al. [22] was able to demonstrate
that the TLR3 agonist and viral analog poly(I:C) were able
to induce higher TSLP mRNA and protein expression in the
epithelium isolated from nasal polyposis patients compared
to epithelium form healthy controls, while a few and con-
trasting observations have been reported on the presence of
IL-25 in CRS. IL-25 mRNA has been reported to be signif-
icantly elevated in ethmoid sinuses of CRSwNP compared
to controls and CRSsNP by Lam et al. [23]. These authors
found that the increased expression of IL-25 they observed
in nasal polyp tissues of patients with CRSwNP correlated
with worse computerized tomography scores and blood
eosinophilia. On the other hand, Miljkovic et al. reported
that IL-25 mRNA was significantly decreased in nasal polyps
compared to ethmoid sinuses of controls [24]. Further
study will be required to investigate the role of IL-25 in
CRSwNP.
Our observation suggests that viral infections may
enhance the T2 biased immunologic response of nasal polyps
through the release of TSLP and IL-25 by epithelial cells. The
function of these cytokines includes induction of a biased T2
innate response, through the engagement of specific receptors
expressed on mast cells and basophils, as well innate type
lymphocytes (ILC2). The effect of viruses on the interaction
of epithelial cells and mast cells has been explored in vitro.
Nagarkar et al. found that airway epithelial cells directly
promoted production of type 2 cytokines in mast cells during
viral infection through the production of TSLP. The same
authors could not detect IL-33 protein in poly(I:C) stimulated
or influenza infected epithelial cells, in agreement with our
results [25].
The role of viral infection in CRSwNP is not clear, but
the frequency of respiratory virus detection in secretions
and tissue samples from patients with CRS is up to 40%,
when real-time polymerase chain reaction is used, according
to a recent report [14]. Either or not viral infections are
pathogenetically involved in polyps development, our results
suggest that the interaction between virus and epithelial cells
of nasal polypsmay enhance the T2 immune response driving
the eosinophilic inflammatory response characteristically
observed in CRSwNP.
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The epithelial cells derived from sinus tissue of patients
with CRSsNP, but not those derived by polyps, responded
to Aspergillus fumigatus and Dermatophagoides pteronyssi-
nus exposure with the production of IL-25 and IL-33
cytokines, but not TSLP, with no difference between atopic
and nonatopic subjects. Both Aspergillus fumigatus and
Dermatophagoides pteronyssinus contain proteolytic allergens
that cause oxidative stress and epithelial damage indepen-
dently on sensitization. Proteases have been shown to initiate
the generation of reactive oxygen species (ROS) by epithelial
cells, leading to oxidation of lipids, signaling through TLR4
and producing T2 cytokines [26].
Surprisingly we could not observe any effect of allergen
stimulation on the release of epithelial cytokines from epithe-
lial cells derived from nasal polyps.
A possible explanation for the different response of
epithelial cells derived from nasal polyps and sinus tissue of
CRSsNP tissue when exposed to poly(I:C) and allergens may
be found in the reported different expression of TLRs. Wang
et al. [27] reported that nasal polyp epithelial cells mainly
express TLR3, which is engaged by poly(I:C) [28], while
expression of TLR4 was very low. On the other hand, mRNA
expression of TLR4 has been reported to be significantly
increased in chronic rhinosinusitis tissues compared with
that in nasal polyps [29] and TLR4 was overexpressed in the
epithelium of chronic rhinosinusitis, evaluated by confocal
analysis [30]. CRSsNP is a heterogeneous disease and the
frequency of type 2 inflammation has been reported to be
even higher than type 1 inflammation in Western world. So
it is not surprising that the epithelial cells derived from sinus
cells of patients with CRSsNP were found to release IL-25 an
IL-33, which are considered TH2 cytokines, when the cells
were exposed to proteases contained in A. fumigatus and D.
pteronyssinus extracts. Similar results have been obtained by
Kouzaki et al., who observed IL-33 release from bronchial
epithelial cells exposed to Alternaria [31].
Actually the biological effects of IL-25 and IL-33 depend
on the tissue environment. For example, ILC2s activated
by IL-25 and IL-33 showed reduced Th2 cytokine secretion
in the presence of plate-bound E-cadherin [32], suggesting
that cell-cell adhesion may play a regulatory role in the
biological effects of these cytokines. In cystic fibrosis IL-
33 has been shown to synergize with chemoattractants to
promote neutrophil recruitment that might be more harmful
than beneficial, like in CRSsNP [33]. IL-33 biology has
evolved and expanded from its predominant role in allergic
pathology to tissue repair and fibrosis [34].
In conclusion, our data suggest that viral infection may
contribute to maintaining and amplifying the T2 immune
response commonly seen in CRSwNP, through the release
of TSLP and IL-25 by epithelial cells of polyps. The role of
IL-25 and IL-33 released by sinus epithelial cells exposed to
proteases stimulation needs to be further investigated.
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